Several studies reported positive correlation between the elevated expression of S100A13 and risk of relapse and status of melanoma patients at follow-up, indicating that S100A13 may play a crucial role in melanoma chemoresistance [8, 9]. This evidence concerns the gene S100A13 and melanoma.